Skip to search formSkip to main contentSkip to account menu

Diffuse cutaneous leishmaniasis

Known as: Leishmaniasis, Diffuse Cutaneous [Disease/Finding], Diffuse Cutaneous Leishmaniases, Leishmaniases, Diffuse Cutaneous 
A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America… 
National Institutes of Health

Related topics

Related topics

7 relations

Narrower (1)

Ethiopian cutaneous leishmaniasis
In BloodMicrobiologicalchemically inducednursing therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis
Diffuse cutaneous leishmaniasis (DCL) is a rare form of leishmaniasis where parasites grow uncontrolled in diffuse lesions across… 
Review
2015
Review
2015
Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management.
Highly Cited
2007
Highly Cited
2007
Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses
Summary  Background  Diffuse cutaneous leishmaniasis (DCL), although rare, is profoundly incapacitating. At present there is no… 
Review
2006
Review
2006
Chemokines in host-parasite interactions in leishmaniasis.
Review
2004
Review
2004
Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review.
The wide variety of Leishmania species responsible for human American cutaneous leishmaniasis combined with the immune mechanisms… 
Review
2000
Review
2000
The epidemiology and control of leishmaniasis in Andean countries.
This paper reviews the current knowledge of leishmaniasis epidemiology in Venezuela, Colombia, Ecuador, Peru, and Bolivia. In all… 
Highly Cited
1993
Highly Cited
1993
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction
The lymphokine profiles were determined in the skin lesions of the three distinct clinical forms of American cutaneous… 
Highly Cited
1993
Highly Cited
1993
The Role of Interferon-γ in the Treatment of Visceral and Diffuse Cutaneous Leishmaniasis
Traditionally, the mainstay of visceral and diffuse cutaneous leishmaniasis therapy has been pentavalent antimony, with… 
Highly Cited
1982
Highly Cited
1982
Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis.
Diffuse cutaneous leishmaniasis is characterized by multiple nonulcerative skin lesions. Histologically, these lesions are… 
Review
1971
Review
1971
Immunological phenomena in leprosy and related diseases.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)